fda semaglutide news The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added Semaglutide FDA Weightloss Approval -

[DOI] [PubMed] [Google Scholar] 56.Salas-Salvado J., Bullo M., Babio N., Martinez-Gonzalez M.A., Ibarrola-Jurado N., Basora J., et al

Training doesnt just spike GLP-1 for a few hours, it also builds lungs, muscle, endurance, mitochondria, resilience, and rewires your entire metabolism

Alternatively, introducing 2mL will result in a concentration of 5mg/mL (equivalent to 1mg per 20 units)

Indianapolis, IN: Eli Lilly and Co

With no guarantee of long-term safety data beyond a few years

Slower gastric emptyinghow the stomach processes foodis the mechanism behind these effects, and they typically diminish within 24 weeks as the body adapts